Pharma Trade Group Seeks To Stop HHS Orphan Drug Rule

Law360, Los Angeles (October 1, 2013, 5:52 PM EDT) -- A pharmaceutical trade group on Monday urged a Washington federal judge to block the U.S. Department of Health and Human Services from implementing a final rule that details how hospitals participating in the 340B drug-discount program can acquire so-called orphan drugs for cheaper prices.

The Pharmaceutical Research and Manufacturers of America sought a preliminary injunction Monday in a suit it filed Friday challenging the final rule allowing hospitals to purchase orphan drugs from group purchasing organizations as long as they are not used for their approved...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.